Table 3.
Relationship Between CVAI with AHI
| Exposure | Model 1 | Model 2 | Model 3 | Model 4 |
|---|---|---|---|---|
| β (95% CI) | β (95% CI) | β (95% CI) | β(95% CI) | |
| AHI | ||||
| CVAI (per SD increase) | 4.72 (4.37 ~ 5.08) | 4.90 (4.46 ~ 5.34) | 4.84 (4.39 ~ 5.29) | 4.84 (4.39 ~ 5.29) |
| Quartile of CVAI | ||||
| Q1 | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) | 1.00 (Reference) |
| Q2 | 2.52 (1.21 ~ 3.83) | 2.51 (1.15 ~ 3.87) | 2.51 (1.14 ~ 3.88) | 2.49 (1.12 ~ 3.86) |
| Q3 | 6.85 (5.66 ~ 8.04) | 6.85 (5.52 ~ 8.17) | 6.74 (5.39 ~ 8.09) | 6.72 (5.37 ~ 8.07) |
| Q4 | 12.32 (11.19 ~ 13.45) | 12.00 (10.60 ~ 13.41) | 11.78 (10.34 ~ 13.22) | 11.75 (10.30 ~ 13.19) |
| P for trend | <0.001 | <0.001 | <0.001 | <0.001 |
Notes: Model 1: unadjust; Model 2: sex, age, current smoking, current drinking, BMI, SBP, DBP; Model 3: sex, age, current smoking, current drinking, BMI, SBP, DBP, HbA1c, BUN, Crea, HDL-C, UA, AST, ALT, FPG, TG; Model 4: sex, age, current smoking, current drinking, BMI, SBP, DBP, HbA1c, BUN, Crea, HDL-C, UA, AST, ALT, FPG, TG, CHD, DM, dyslipidemia, lipid-lowering drugs, antihypertensive drugs, antidiabetic drugs. P for trend: refers to the statistical significance of the trend across ordered groups.
Abbreviations: OR, Odds Ratio; CI, Confidence Interval. Other abbreviations, see Table 1.